Albert Bourla, Pfizer CEO (Hannes P Albert/picture-alliance/dpa/AP Images)
February 19, 2025 10:05 AM ESTUpdated 12:05 PM
Pharma

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

Andrew Dunn

Senior Biopharma Correspondent

WASH­ING­TON — Over 500 phar­ma ex­ec­u­tives, lob­by­ists, con­sul­tants and oth­er in­dus­try mem­bers gath­ered a cou­ple miles from the White House on Tues­day, as top in­dus­try lead­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Roche no longer wants to be where ‘DNA se­quenc­ing goes to die’

Trump’s HHS de­fends drug price ne­go­ti­a­tions in No­var­tis suit

First meet­ing of CDC vac­cine ad­vi­sors in the Kennedy era is post­poned

How Keymed steered the Chi­na-to-US New­Co mod­el in biotech

Trump’s picks for NIH, CMS say they’ll un­load in­dus­try in­vest­ments

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times